Latest Breaking News On - Bio receptor activity intelligence network - Page 1 : comparemela.com
Psilera Raises $2 5 Million with Oversubscribed Series Seed from Leading Institutional Investors to Accelerate Clinical Pipeline Focused on DMT
prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
Psilera Raises $2 5M in Seed Funding
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.
Psilera Expands Team to Include World-Class Researchers and Industry Leaders to Bolster Clinical Psychedelic Pipeline
Share Article TAMPA, Fla. (PRWEB) May 11, 2021
Psilera Bioscience (“Psilera”), a Florida-based biotechnology company specializing in the clinical development of psychedelics and analogues is pleased to announce the latest additions to its roster of talent. All bring unique insight to strengthen company leadership with research and clinical management experience and adding value to Psilera’s drug pipeline.
Psilera has hired Jeanine Yacoub, MS in the Synthetic and Medicinal Chemistry role. “Jeanine has been part of Psilera since we first began research at USF, and we’re thrilled to bring her on full-time to continue developing synthetic methodologies towards new psychedelic analogues,” said Dr. Jackie von Salm, Co-Founder & CSO of Psilera Bioscience.